Inge Hamming

7.6k total citations · 1 hit paper
21 papers, 5.4k citations indexed

About

Inge Hamming is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Inge Hamming has authored 21 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Nephrology. Recurrent topics in Inge Hamming's work include Renin-Angiotensin System Studies (15 papers), Hormonal Regulation and Hypertension (9 papers) and Apelin-related biomedical research (3 papers). Inge Hamming is often cited by papers focused on Renin-Angiotensin System Studies (15 papers), Hormonal Regulation and Hypertension (9 papers) and Apelin-related biomedical research (3 papers). Inge Hamming collaborates with scholars based in Netherlands, United States and United Kingdom. Inge Hamming's co-authors include Harry van Goor, A. Titia Lely, G. Navis, Wim Timens, GJ Navis, Ron Korstanje, Nigel M. Hooper, M. E. Cooper, Bart L. Haagmans and Annie Michaud and has published in prestigious journals such as Kidney International, American Journal Of Pathology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Inge Hamming

21 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

2004 4.1k citations Inge Hamming, Wim Timens et al. The Journal of Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge Hamming Netherlands	14	3.5k	1.7k	726	721	471	21	5.4k
G. Navis Netherlands	18	3.3k 1.0×	1.7k 1.0×	755 1.0×	662 0.9×	391 0.8×	35	5.7k
A. Titia Lely Netherlands	28	3.2k 0.9×	1.6k 0.9×	810 1.1×	644 0.9×	385 0.8×	120	6.6k
Jing Wan China	19	2.3k 0.7×	1.4k 0.8×	897 1.2×	469 0.7×	189 0.4×	45	4.0k
Yumiko Imai Japan	33	2.3k 0.7×	824 0.5×	706 1.0×	1.3k 1.7×	361 0.8×	64	6.1k
Keiji Kuba Japan	29	2.3k 0.6×	845 0.5×	744 1.0×	1.3k 1.7×	360 0.8×	59	5.2k
Sheila K. Patel Australia	32	786 0.2×	619 0.4×	849 1.2×	642 0.9×	427 0.9×	92	3.3k
Ferhat Meziani France	37	2.9k 0.8×	2.7k 1.5×	440 0.6×	947 1.3×	94 0.2×	110	7.2k
He Huang China	31	2.6k 0.7×	1.6k 0.9×	2.3k 3.2×	1.2k 1.7×	144 0.3×	163	6.1k
Paul‐Michel Mertès France	42	1.6k 0.5×	955 0.5×	1.0k 1.4×	405 0.6×	78 0.2×	202	7.5k
María José Soler Spain	34	1.2k 0.3×	457 0.3×	1.3k 1.8×	834 1.2×	1.4k 3.0×	203	4.8k

Countries citing papers authored by Inge Hamming

Since Specialization

Citations

This map shows the geographic impact of Inge Hamming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Hamming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Hamming more than expected).

Fields of papers citing papers by Inge Hamming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Hamming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Hamming. The network helps show where Inge Hamming may publish in the future.

Co-authorship network of co-authors of Inge Hamming

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Hamming. A scholar is included among the top collaborators of Inge Hamming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Hamming. Inge Hamming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Slagter, Kirsten W., Gerry M. Raghoebar, Inge Hamming, Jiska Meijer, & Arjan Vissink. (2020). Effect of frenotomy on breastfeeding and reflux: results from the BRIEF prospective longitudinal cohort study. Clinical Oral Investigations. 25(6). 3431–3439. 12 indexed citations

Voort, Peter H. J. van der, Jill Moser, D. F. Zandstra, et al.. (2020). Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon. 6(8). e04696–e04696. 64 indexed citations

Nijenhuis, Tom, Alexis Sloan, Joost G.J. Hoenderop, et al.. (2011). Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway. American Journal Of Pathology. 179(4). 1719–1732. 174 indexed citations

Kamilić, Jelena, Inge Hamming, Reinhold Kreutz, et al.. (2009). Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. Hypertension Research. 33(2). 123–128. 17 indexed citations

Borst, Martin H. de, Jai Prakash, Maria Sandovici, et al.. (2009). c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation. Journal of Pharmacology and Experimental Therapeutics. 331(3). 896–905. 55 indexed citations

Sluimer, Judith C., Inge Hamming, Harry van Goor, et al.. (2008). Angiotensin‐converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. The Journal of Pathology. 215(3). 273–279. 92 indexed citations

Hamming, Inge, Harry van Goor, Anthony J. Turner, et al.. (2008). Differential regulation of renal angiotensin‐converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats. Experimental Physiology. 93(5). 631–638. 73 indexed citations

Westendorp, Bart, Inge Hamming, Mariusz K. Szymanski, et al.. (2008). Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. European Journal of Pharmacology. 602(2-3). 373–379. 2 indexed citations

Waanders, Femke, Vishal S. Vaidya, Harry van Goor, et al.. (2008). Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial. American Journal of Kidney Diseases. 53(1). 16–25. 100 indexed citations

10.

Hamming, Inge. (2008). Novel insights in the pathogenesis of renal interstitial damage during ACE inhibition: a role for ACE2 and the (pro)renin-receptor?. University of Groningen research database (University of Groningen / Centre for Information Technology). 1 indexed citations

11.

Hamming, Inge. (2008). Novel insights in the pathogenesis of renal interstitial damage during ACE inhibition. 1 indexed citations

12.

Krebs, Christian F., Inge Hamming, Oliver M. Steinmetz, et al.. (2007). Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney International. 72(6). 725–730. 75 indexed citations

13.

Kramer, Andrea B., et al.. (2007). Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney International. 71(5). 417–424. 47 indexed citations

14.

Hamming, Inge, M. E. Cooper, Bart L. Haagmans, et al.. (2007). The emerging role of ACE2 in physiology and disease. The Journal of Pathology. 212(1). 1–11. 331 indexed citations

15.

Hamming, Inge, et al.. (2006). Regulation of the renal renin/(pro)renin receptor (RPR) by ACE inhibition and sodium restriction. Journal of Hypertension. 24. 6 indexed citations

16.

Hamming, Inge, et al.. (2006). ACE inhibition during low salt intake decreases renal ACE2 expression in healthy and nephrotic rats. Journal of Hypertension. 24. 1 indexed citations

17.

Steinmetz, Oliver M., Ulf Panzer, Christian F. Krebs, et al.. (2006). Antihypertensive therapy induces compartment-specific chemokine expression and a Th1 immune response in the clipped kidney of Goldblatt hypertensive rats. American Journal of Physiology-Renal Physiology. 292(2). F876–F887. 16 indexed citations

18.

Hamming, Inge, et al.. (2006). ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. The Journal of Pathology. 209(1). 129–139. 40 indexed citations

19.

Hamming, Inge, et al.. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology. 203(2). 631–637. 4117 indexed citations breakdown →

20.

Lely, A. Titia, Inge Hamming, Harry van Goor, & GJ Navis. (2004). Renal ACE2 expression in human kidney disease. The Journal of Pathology. 204(5). 587–593. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact